Click for best price
Postpemic Era Gastrointestinal Cancer Treatment Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Gastrointestinal Cancer Treatment Market Segment Research Report 2022, which aims to sort out the development status and trends of the Gastrointestinal Cancer Treatment industry at home and abroad, estimate the overall market scale of the Gastrointestinal Cancer Treatment industry and the market share of major countries, Gastrointestinal Cancer Treatment industry, and study and judge the downstream market demand of Gastrointestinal Cancer Treatment through systematic research, Analyze the competition pattern of Gastrointestinal Cancer Treatment, so as to help solve the pain points of various stakeholders in Gastrointestinal Cancer Treatment industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Gastrointestinal Cancer Treatment Market by Research Include
- USA
- Europe
- China
- Japan
- India
- Korea
- Southeast Asia
Competitive Analysis; Who are the Major Players in Gastrointestinal Cancer Treatment Market
- Eli Lilly
- F. Hoffmann
- GlaxoSmithKline
- Merck
- Novartis AG
- Otsuka Holdings
- Stryker Corporation
- Boston Scientific Corporation
- Johnson and Johnson
- CONMED Corporation
- Bristol-Myers Squibb
- Pfizer
- Celltrion Inc
- Amgen Limited
- Celgene Corporation
- Sanofi
Major Type of Gastrointestinal Cancer Treatment Covered in Research report:
- Surgery
- Targeted Drugs Therapy
- Chemo Therapy
- Adjuvant Chemotherapy
- Radiation Therapy
Application Segments Covered in Research Market
- Hospitals
- Clinics
- Research Centers
- Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Gastrointestinal Cancer Treatment Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
97 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Gastrointestinal Cancer Treatment Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Gastrointestinal Cancer Treatment Market by Value
2.2.1 Global Gastrointestinal Cancer Treatment Revenue by Type
2.2.2 Global Gastrointestinal Cancer Treatment Market by Value
2.3 Global Gastrointestinal Cancer Treatment Market by Sales
2.3.1 Global Gastrointestinal Cancer Treatment Sales by Type
2.3.2 Global Gastrointestinal Cancer Treatment Market by Sales
3. The Major Driver of Gastrointestinal Cancer Treatment Industry
3.1 Historical & Forecast Global Gastrointestinal Cancer Treatment Sales and Revenue (2018-2028)
3.2 Largest Application for Gastrointestinal Cancer Treatment (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Gastrointestinal Cancer Treatment Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Gastrointestinal Cancer Treatment Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Gastrointestinal Cancer Treatment Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Gastrointestinal Cancer Treatment Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Gastrointestinal Cancer Treatment Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Gastrointestinal Cancer Treatment Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Gastrointestinal Cancer Treatment Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Gastrointestinal Cancer Treatment Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Gastrointestinal Cancer Treatment Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Gastrointestinal Cancer Treatment Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Gastrointestinal Cancer Treatment Average Price Trend
13.1 Market Price for Each Type of Gastrointestinal Cancer Treatment in US (2018-2022)
13.2 Market Price for Each Type of Gastrointestinal Cancer Treatment in Europe (2018-2022)
13.3 Market Price for Each Type of Gastrointestinal Cancer Treatment in China (2018-2022)
13.4 Market Price for Each Type of Gastrointestinal Cancer Treatment in Japan (2018-2022)
13.5 Market Price for Each Type of Gastrointestinal Cancer Treatment in India (2018-2022)
13.6 Market Price for Each Type of Gastrointestinal Cancer Treatment in Korea (2018-2022)
13.7 Market Price for Each Type of Gastrointestinal Cancer Treatment in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Gastrointestinal Cancer Treatment in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Gastrointestinal Cancer Treatment Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Gastrointestinal Cancer Treatment
15. Gastrointestinal Cancer Treatment Competitive Landscape
15.1 Eli Lilly
15.1.1 Eli Lilly Company Profiles
15.1.2 Eli Lilly Product Introduction
15.1.3 Eli Lilly Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 F. Hoffmann
15.2.1 F. Hoffmann Company Profiles
15.2.2 F. Hoffmann Product Introduction
15.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 GlaxoSmithKline
15.3.1 GlaxoSmithKline Company Profiles
15.3.2 GlaxoSmithKline Product Introduction
15.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Merck
15.4.1 Merck Company Profiles
15.4.2 Merck Product Introduction
15.4.3 Merck Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Novartis AG
15.5.1 Novartis AG Company Profiles
15.5.2 Novartis AG Product Introduction
15.5.3 Novartis AG Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Otsuka Holdings
15.6.1 Otsuka Holdings Company Profiles
15.6.2 Otsuka Holdings Product Introduction
15.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Stryker Corporation
15.7.1 Stryker Corporation Company Profiles
15.7.2 Stryker Corporation Product Introduction
15.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Boston Scientific Corporation
15.8.1 Boston Scientific Corporation Company Profiles
15.8.2 Boston Scientific Corporation Product Introduction
15.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Johnson and Johnson
15.9.1 Johnson and Johnson Company Profiles
15.9.2 Johnson and Johnson Product Introduction
15.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 CONMED Corporation
15.10.1 CONMED Corporation Company Profiles
15.10.2 CONMED Corporation Product Introduction
15.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Bristol-Myers Squibb
15.12 Pfizer
15.13 Celltrion Inc
15.14 Amgen Limited
15.15 Celgene Corporation
15.16 Sanofi
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Gastrointestinal Cancer Treatment Industry (Volume)
Figure 2. Gastrointestinal Cancer Treatment Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2022
Figure 5. US Gastrointestinal Cancer Treatment Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Gastrointestinal Cancer Treatment Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Gastrointestinal Cancer Treatment Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Gastrointestinal Cancer Treatment Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Gastrointestinal Cancer Treatment Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Gastrointestinal Cancer Treatment Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Gastrointestinal Cancer Treatment Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Gastrointestinal Cancer Treatment Revenue, by Type (Million USD) (2018-2028)
Table 4. Gastrointestinal Cancer Treatment Sales, by Type (K Unit) (2018-2028)
Table 5. Gastrointestinal Cancer Treatment Sales (K Unit) by Application (2018-2028)
Table 6. Gastrointestinal Cancer Treatment Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Gastrointestinal Cancer Treatment Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Gastrointestinal Cancer Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Gastrointestinal Cancer Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Gastrointestinal Cancer Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Gastrointestinal Cancer Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Gastrointestinal Cancer Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Gastrointestinal Cancer Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Gastrointestinal Cancer Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Gastrointestinal Cancer Treatment in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Gastrointestinal Cancer Treatment in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Gastrointestinal Cancer Treatment in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Gastrointestinal Cancer Treatment in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Gastrointestinal Cancer Treatment in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Gastrointestinal Cancer Treatment in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Gastrointestinal Cancer Treatment in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Eli Lilly Profiles
Table 61. Eli Lilly Gastrointestinal Cancer Treatment Product Introduction
Table 62. Eli Lilly Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Eli Lilly Strategic initiatives
Table 64. F. Hoffmann Profiles
Table 65. F. Hoffmann Gastrointestinal Cancer Treatment Product Introduction
Table 66. F. Hoffmann Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. F. Hoffmann Strategic initiatives
Table 68. GlaxoSmithKline Profiles
Table 69. GlaxoSmithKline Gastrointestinal Cancer Treatment Product Introduction
Table 70. GlaxoSmithKline Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. GlaxoSmithKline Strategic initiatives
Table 72. Merck Profiles
Table 73. Merck Gastrointestinal Cancer Treatment Product Introduction
Table 74. Merck Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Merck Strategic initiatives
Table 76. Novartis AG Profiles
Table 77. Novartis AG Gastrointestinal Cancer Treatment Product Introduction
Table 78. Novartis AG Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Novartis AG Strategic initiatives
Table 80. Otsuka Holdings Profiles
Table 81. Otsuka Holdings Gastrointestinal Cancer Treatment Product Introduction
Table 82. Otsuka Holdings Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Otsuka Holdings Strategic initiatives
Table 84. Stryker Corporation Profiles
Table 85. Stryker Corporation Gastrointestinal Cancer Treatment Product Introduction
Table 86. Stryker Corporation Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Stryker Corporation Strategic initiatives
Table 88. Boston Scientific Corporation Profiles
Table 89. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product Introduction
Table 90. Boston Scientific Corporation Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Boston Scientific Corporation Strategic initiatives
Table 92. Johnson and Johnson Profiles
Table 93. Johnson and Johnson Gastrointestinal Cancer Treatment Product Introduction
Table 94. Johnson and Johnson Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Johnson and Johnson Strategic initiatives
Table 97. CONMED Corporation Profiles
Table 98. CONMED Corporation Gastrointestinal Cancer Treatment Product Introduction
Table 99. CONMED Corporation Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. CONMED Corporation Strategic initiatives
Table 101. Bristol-Myers Squibb Profiles
Table 102. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product Introduction
Table 103. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Bristol-Myers Squibb Strategic initiatives
Table 105. Pfizer Profiles
Table 106. Pfizer Gastrointestinal Cancer Treatment Product Introduction
Table 107. Pfizer Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Pfizer Strategic initiatives
Table 109. Celltrion Inc Profiles
Table 110. Celltrion Inc Gastrointestinal Cancer Treatment Product Introduction
Table 111. Celltrion Inc Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Celltrion Inc Strategic initiatives
Table 113. Amgen Limited Profiles
Table 114. Amgen Limited Gastrointestinal Cancer Treatment Product Introduction
Table 115. Amgen Limited Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. Amgen Limited Strategic initiatives
Table 117. Celgene Corporation Profiles
Table 118. Celgene Corporation Gastrointestinal Cancer Treatment Product Introduction
Table 119. Celgene Corporation Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 120. Celgene Corporation Strategic initiatives
Table 121. Sanofi Profiles
Table 122. Sanofi Gastrointestinal Cancer Treatment Product Introduction
Table 123. Sanofi Gastrointestinal Cancer Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 124. Sanofi Strategic initiatives
